{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/irritable-bowel-syndrome/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"d335e933-3ba3-56d3-9f86-ccb100e2cb09","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 56fd79d1-3d8e-4c2f-b3f7-a7f300bd26e0 --><h2>How should I assess a person with suspected irritable bowel syndrome?</h2><!-- end field 56fd79d1-3d8e-4c2f-b3f7-a7f300bd26e0 -->","summary":"","htmlStringContent":"<!-- begin item 18b9e0f8-6fef-40a5-8af4-a7f300bd1d56 --><!-- begin field c8bceb3a-ef5b-4f0b-b86e-a7f300bd26e0 --><p><strong>If a diagnosis of irritable bowel syndrome (IBS) is <a class=\"topic-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/diagnosis/diagnosis/\">suspected</a>, assess the person's clinical features:</strong></p><ul><li><strong>Ask about:</strong><ul><li>The type and severity of <a class=\"topic-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/diagnosis/diagnosis/\">symptoms</a>.</li><li>The impact of symptoms on daily functioning such as home, work, school, and leisure activities.</li><li>Any clinical features suggesting an <a class=\"topic-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/diagnosis/differential-diagnosis/\">alternative diagnosis</a>, including a serious or life-threatening condition, and arrange admission or referral if appropriate. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gastrointestinal-tract-lower-cancers-recognition-referral/\">Gastrointestinal tract (lower) cancers - recognition and referral</a> for more information on red flag indicators.</li><li>The person's diet (including fibre intake), nutrition, and any known food triggers (such as alcohol, caffeine, spicy and fatty foods) — consider the use of a food diary to determine an association between specific foods and symptoms.</li><li>The person's exercise and physical activity levels.</li><li>Any recent stresses, anxiety, or depression. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a> and <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a> for more information.</li></ul></li><li><strong>Examine the person:</strong><ul><li>Check the weight, calculate the body mass index (BMI), and assess for unintended or unexplained weight loss.</li><li>Palpate the abdomen for signs of tenderness or masses.</li><li>Perform a rectal examination, with the person's consent, to exclude perianal or rectal pathology.</li></ul></li><li><strong>Consider arranging the following investigations</strong> to exclude an <a class=\"topic-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/diagnosis/differential-diagnosis/\">alternative diagnosis</a>.<ul><li>Full blood count (FBC) — to assess for anaemia, and a raised platelet count may suggest active inflammation as an alternative cause for symptoms.</li><li>Inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) — may be raised if there is active inflammation or infection.</li><li>Coeliac serology — to exclude coeliac disease, particularly if there is diarrhoea-predominant IBS or mixed symptoms.</li><li>Note: IBS is a diagnosis of exclusion, there is no specific investigation to confirm a diagnosis.</li></ul></li></ul><!-- end field c8bceb3a-ef5b-4f0b-b86e-a7f300bd26e0 --><!-- end item 18b9e0f8-6fef-40a5-8af4-a7f300bd1d56 -->","topic":{"id":"4bb8acbd-d2b1-5f93-9ffa-0a3f11076292","topicId":"2c2fedc7-3daf-462e-b168-78c86cb2a2ec","topicName":"Irritable bowel syndrome","slug":"irritable-bowel-syndrome","lastRevised":"Last revised in October 2020","chapters":[{"id":"e08d84ab-7283-58cb-9873-bebac62d6494","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"09b06ced-d018-5c24-883c-ff37be197b2d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"14d879ef-e87a-571a-a829-4f236e5265b8","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0858c465-429d-5390-b8bd-432cb1d0fb46","slug":"changes","fullItemName":"Changes"},{"id":"fbcab9c4-bcb5-5d61-855f-1ec3aef8fdfe","slug":"update","fullItemName":"Update"}]},{"id":"d1d333cb-5ad0-5c55-987c-0d9bcdd7219b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"df8485dd-d258-554e-91a1-cfae144c8f3a","slug":"goals","fullItemName":"Goals"},{"id":"92f70986-7a29-5aaf-8c2b-e24b675e84dc","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4cbbe159-85f5-573d-a6f1-cf83b24c7513","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b054d7f7-3303-57ad-bc98-df229e629e9c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d5eb318d-cbd0-556b-8ce7-6c20aab02bc0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c7ecf3c9-b183-5b40-99b8-9fa4ac12bfb8","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"156f0f16-df4f-5fcf-94da-2e9dfe0d9ae7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d091ffcd-a585-5def-b8a6-6a8e82be964d","slug":"definition","fullItemName":"Definition"},{"id":"08e0e6c7-a53c-53d9-a8ff-37b9af0475a9","slug":"causes","fullItemName":"Causes"},{"id":"2af080fe-338c-5682-927e-df91b2056310","slug":"prevalence","fullItemName":"Prevalence"},{"id":"668a8344-5367-57b6-be24-4904a8b84c09","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"d71af51f-0d21-583c-ae74-cdeefe5efe9a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1e13d165-63d9-5000-8411-3cb047828b3a","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"d335e933-3ba3-56d3-9f86-ccb100e2cb09","slug":"assessment","fullItemName":"Assessment"},{"id":"f6a63ea2-fb31-5f4c-b6ca-21ee922d5615","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a0f45b9c-efa3-5c88-a5bc-3cd26c71883f","fullItemName":"Management","slug":"management","subChapters":[{"id":"d4748fe8-65f9-5b0b-bbd0-32469fde1c78","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"86d862ff-43f3-59ac-9769-c4bc0ec5ea9b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4517eb7c-ad75-5732-86b2-ea7cf18e7a93","slug":"bulk-forming-laxatives","fullItemName":"Bulk-forming laxatives"},{"id":"712646a9-5a89-5454-b98e-b2d2dce9ac3d","slug":"linaclotide","fullItemName":"Linaclotide"},{"id":"b36ea15d-0d7e-5080-9c77-f7f1b274523b","slug":"loperamide","fullItemName":"Loperamide"},{"id":"c7ea4d4a-3d5a-5cdb-8999-e01670699563","slug":"antispasmodic-drugs","fullItemName":"Antispasmodic drugs"},{"id":"b5eff265-676e-584f-a5d6-0a4714238d8f","slug":"antidepressant-drugs","fullItemName":"Antidepressant drugs"}]},{"id":"2c06aa30-84a6-5e94-8d6f-1d960d28dcdc","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"25c14e40-3957-5b26-aa34-0afc73225fdd","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"38e74c6b-daec-50bd-a23a-3aa30b83db82","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c6497438-25eb-590a-9d9d-dfe08a17fb21","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"36885cba-cf5e-5cab-a474-2c0fc504fa91","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"89b5e4f9-0ed1-5b13-8258-3ba2b6f5b43e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d3199940-6be9-57b4-a2b0-2ee240db6d97","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"5667ce2f-151b-57f5-9fde-07b6339b1aef","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d71af51f-0d21-583c-ae74-cdeefe5efe9a","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"44f2a764-563b-500a-90c0-1f0f5a00f244","slug":"basis-for-recommendation-5e9","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 071d5e2a-6986-465d-a677-a7f300bde1a5 --><h3>Basis for recommendation</h3><!-- end field 071d5e2a-6986-465d-a677-a7f300bde1a5 -->","summary":null,"htmlStringContent":"<!-- begin item 5e9c9ccf-03ca-4c4d-ae8d-a7f300bde017 --><!-- begin field 33f6734d-ef1c-44b1-aa47-a7f300bde1a5 --><p>The recommendations on assessment are based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Irritable bowel syndrome in adults: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">NICE, 2017</a>], the British Dietetic Association (BDA) publication <em>BDA systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">McKenzie, 2016</a>], and expert opinion in review articles on irritable bowel syndrome [<a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">Ford, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">Wilkins, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">Chey, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">Halland, 2015</a>] and a review article on the Rome IV criteria for functional gastrointestinal disorders [<a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">Drossman, 2016</a>].</p><ul><li>An assessment of the person's bowel habit and stool type will determine whether the person has diarrhoea-predominant, constipation-predominant, or mixed irritable bowel syndrome symptoms. This allows management to be targeted to the different sub-types [<a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">Chey, 2015</a>].</li><li>An assessment of psychosocial stressors or co-morbidity is important, as initial presentations and exacerbations of IBS symptoms are often affected by psychological stress or the person's emotional response to stress [<a class=\"bibliography-reference internal-reference\" href=\"/topics/irritable-bowel-syndrome/references/\">Drossman, 2016</a>].</li></ul><!-- end field 33f6734d-ef1c-44b1-aa47-a7f300bde1a5 --><!-- end item 5e9c9ccf-03ca-4c4d-ae8d-a7f300bde017 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}